beta-amyloid

researchers are investigating the role of beta-amyloid in alzheimer's disease.

the presence of beta-amyloid plaques is a hallmark of alzheimer's pathology.

scientists are developing therapies targeting beta-amyloid aggregation.

beta-amyloid levels in cerebrospinal fluid can be measured to assess risk.

genetic mutations can increase beta-amyloid production in some individuals.

the formation of beta-amyloid fibrils contributes to plaque development.

early detection of beta-amyloid deposits is crucial for potential interventions.

beta-amyloid clearance mechanisms are being explored as therapeutic targets.

the relationship between beta-amyloid and tau protein is complex.

imaging techniques can visualize beta-amyloid accumulation in the brain.

reducing beta-amyloid production is a key goal in alzheimer's research.